We are live on ! Find out more
BGIM

Boussard & Gavaudan Investment Management Portfolio holdings

AUM $1.06B
1-Year Est. Return 4.58%
This Fund
S&P 500
This Quarter Est. Return
+21.12%
1 Year Est. Return
+4.58%
3 Year Est. Return
+25.82%
5 Year Est. Return
+33.18%
10 Year Est. Return
+356.42%
AUM
$527K
AUM Growth
-$461M
Cap. Flow
-$198M
Cap. Flow %
-37,549.24%
Top 10 Hldgs %
85.67%
Holding
53
New
24
Increased
3
Reduced
3
Closed
11

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$204M
2
RTX icon
RTX Corp
RTX
+$62.4M
3
ASH icon
Ashland
ASH
+$16.5M
4
QGEN icon
Qiagen
QGEN
+$11.2M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$8.34M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 45.1%
2 Industrials 12.33%
3 Materials 9.37%
4 Financials 6.94%
5 Healthcare 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY.RT
26
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$1.42K 0.27%
416,793
+10,984
+3% +$39.6K
LCAHW
27
DELISTED
Landcadia Holdings II, Inc. Warrant
LCAHW
$1.17K 0.22%
+217,300
New +$157K
MAPS
28
DELISTED
WM TECHNOLOGY INC A
MAPS
$811 0.15%
800,000
THBRW
29
DELISTED
Thunder Bridge Acquisition II, Ltd. Warrants
THBRW
$636 0.12%
400,000
GSAH.U
30
DELISTED
GS Acquisition Holdings Corp II Units, each consisting of one share of Class A Common Stock and one-
GSAH.U
$520 0.1%
+50,000
New +$526K
QGEN icon
31
Qiagen
QGEN
$8.88B
$504 0.1%
11,024
-251,071
-96% -$11.2M
SFTW.WS
32
DELISTED
Osprey Technology Acquisition Corp. Redeemable Warrants, each whole Warrant exercisable for one shar
SFTW.WS
$400 0.08%
400,000
CCXX.WS
33
DELISTED
Churchill Capital Corp III Warrants, each exercisable for one share of Class A common stock at an ex
CCXX.WS
$338 0.06%
+125,000
New +$230K
SCPE.WS
34
DELISTED
SC Health Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an
SCPE.WS
$321 0.06%
+300,000
New +$306K
SRTAW
35
DELISTED
Strata Critical Medical Inc Warrants
SRTAW
$270 0.05%
300,000
MAPSW
36
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$225 0.04%
+450,000
New +$167K
OAC.WS
37
DELISTED
Oaktree Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at
OAC.WS
$196 0.04%
+133,333
New +$155K
GHIVW
38
DELISTED
Gores Holdings IV, Inc. Warrant
GHIVW
$194 0.04%
+125,000
New +$183K
CCX.WS
39
DELISTED
Churchill Capital Corp II Warrants, each exercisable for one share of Class A common stock at an exe
CCX.WS
$178 0.03%
+66,666
New +$123K
ASTSW
40
DELISTED
AST SpaceMobile, Inc. Warrant
ASTSW
$150 0.03%
+150,000
New +$95.3K
ALUS.WS
41
DELISTED
Alussa Energy Acquisition Corp Warrants
ALUS.WS
$142 0.03%
275,000
CPAAW
42
DELISTED
Conyers Park II Acquisition Corp. Warrant
CPAAW
$77 0.01%
+37,500
New +$67.4K
ASH icon
43
Ashland
ASH
$3.42B
-324,228
Closed -$16.5M
LBRDK icon
44
Liberty Broadband Class C
LBRDK
$5.07B
-73,651
Closed -$8.34M
OMC icon
45
Omnicom Group
OMC
$23.5B
-22,242
Closed -$1.24M
RTX icon
46
RTX Corp
RTX
$300B
-1,012,908
Closed -$62.4M
SXT icon
47
Sensient Technologies
SXT
$5.55B
-81,131
Closed -$3.58M
SCPE.U
48
DELISTED
SC Health Corporation Units, each consisting of one Class A ordinary share, $0.0001 par value, and o
SCPE.U
-600,000
Closed -$6.12M
CCX.U
49
DELISTED
Churchill Capital Corp II
CCX.U
-200,000
Closed -$2.07M
GHIVU
50
DELISTED
Gores Holdings IV, Inc. Unit
GHIVU
-500,000
Closed -$5.01M

Similar funds

Boussard & Gavaudan Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, Boussard & Gavaudan Investment Management held 53 positions worth $527K, down 100% from $461M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Boussard & Gavaudan Investment Management withdrew a net $198M in Q2 2020, closing 11 positions and reducing 3 holdings. Its most notable exit was Allergan plc, an estimated $204M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 45% of assets, up from 0% a quarter earlier, followed by Industrials and Materials.

Against the trend, Boussard & Gavaudan Investment Management opened a new position in Otis Worldwide worth $14.7K.

  • Boussard & Gavaudan Investment Management's largest Q2 2020 buy was Otis Worldwide: 262,203 shares worth $14.7K.
  • Boussard & Gavaudan Investment Management added most to Tiffany & Co. in Q2 2020, an estimated $36.2M increase.
  • Boussard & Gavaudan Investment Management's biggest Q2 2020 reduction was Qiagen, cutting an estimated $11.2M.
  • Boussard & Gavaudan Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $204M.
  • Boussard & Gavaudan Investment Management's ten largest holdings make up 86% of its $527K portfolio in Q2 2020.
  • Boussard & Gavaudan Investment Management opened 24 new positions and closed 11 in Q2 2020.
  • Boussard & Gavaudan Investment Management's portfolio value fell 100% quarter-over-quarter to $527K.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q2 2020, filed 9 Jul 2020.